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Geminin Promotes an Epithelial-to-Mesenchymal Transition
in an Embryonic Stem Cell Model of Gastrulation
Nicole Slawny and K. Sue O’Shea
Geminin is a nuclear protein that performs the related functions of modulating cell cycle progression by binding
Cdt1, and controlling differentiation by binding transcription factors. Since embryonic stem cells (ESC) and the
epiblast share a similar gene expression profile and an attenuated cell cycle, ESC form an accessible and tractable
model system to study lineage choice at gastrulation. We derived several ESC lines in which Geminin can be
inducibly expressed, and employed short hairpin RNAs targeting Geminin. As in the embryo, a lack of Geminin
protein resulted in DNA damage and cell death. In monolayer culture, in defined medium, Geminin supported
neural differentiation; however, in three-dimensional culture, overexpression of Geminin promoted me-
sendodermal differentiation and epithelial-to-mesenchymal transition. In vitro, ESC overexpressing Geminin
rapidly recolonized a wound, downregulated E-cadherin expression, and activated Wnt signaling. We suggest
that Geminin may promote differentiation via binding Groucho/TLE proteins and upregulating canonical
Wnt signaling.
Introduction
Just before gastrulation, the mouse embryo expandsfrom 20–25 cells to *660 cells in roughly 1.5 days [1,2].
During this period of rapid cell division, it is critical that the
epiblast remains undifferentiated; cells spend the majority of
their cycle in the S phase with a very short G1 [3,4], unlike
somatic cells where G1 predominates. This attenuated cell
cycle likely underlies the rapid expansion capability of the
epiblast and may also play an important role in maintaining
its pluripotency and inhibiting differentiation.
At gastrulation, the epiblast is allocated to 3 germ layers:
endoderm, mesoderm, and ectoderm. This process in-
volves an epithelial-to-mesenchymal transition (EMT),
complex morphogenetic movements, and differential gene
expression that culminate in lineage-fate decisions. Despite
the importance of understanding cell fate choice in early
development, progress has been limited by the early le-
thality of many gene-null models and the general inac-
cessibility of the mammalian embryo at this early stage.
Since embryonic stem cells (ESC) are derived from the in-
ner cell mass of the blastocyst, they retain the ability to
generate all cells of the mouse embryo [5,6]. In addition,
ESC and the epiblast have similar gene expression patterns
and share an uniquely abbreviated cell cycle. Because of
these similarities, differentiation of ESC offers a simple
model of cell fate choice at gastrulation and an experi-
mentally tractable system to examine the gene function in
development.
One gene that has been shown to modulate both cell cycle
progression and differentiation is Geminin, which was
identified in 2 independent functional screens in Xenopus
embryos: the first screen to identify genes that were de-
graded during mitosis [7], and the second to identify genes
involved in neural induction [8]. Geminin functions as a cell
cycle-licensing factor, permitting replication of the genome
once and only once during mitosis [9,10]; Geminin-null
mouse embryos die by E3.5 due to endoreduplication errors
[11,12]. Late in the S phase, Geminin binds and inhibits
the interaction of Cdt1 with DNA origins of replication,
and must then be degraded during the M phase to allow
replication.
Geminin overexpression was reported to expand the Xe-
nopus neural plate by inhibiting BMP signaling, independent
of an effect on cell division [8]. Expression of Geminin is
restricted to the neural plate in the Xenopus embryos by the
Tcf and Vent sites [13], indicating that BMP and Wnt path-
way signaling cooperate to control Geminin expression
during differentiation. Geminin has also been proposed to
control the transition from pluripotency to differentiation in
the Xenopus embryo by epigenetically repressing the tran-
scriptional response to the Activin/Nodal, FGF, and BMP
pathways in conjunction with polycomb proteins, thus pro-
moting differentiation of the neural ectoderm and inhibiting
non-neural lineages [14].
To determine how Geminin functions in lineage specifi-
cation, we developed several ESC lines in which Geminin
can be inducibly overexpressed, and employed short hairpin
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RNAs (shRNA) to target the native Geminin mRNA. Re-
duction of Geminin protein via targeted shRNA resulted in
cell death due to DNA damage. In monolayer culture, in
defined medium, Geminin overexpression supported differ-
entiation of neural precursor cells and neurons. In embryoid
bodies (EBs); however, overexpression of Geminin induced
mesendodermal differentiation and expression of genes in-
volved in EMT. Initiation of mesendodermal differentia-
tion appears to result from Wnt pathway activation possibly
by binding of Geminin to Groucho/Transducin-Like En-
hancer of split (TLE) proteins in the nucleus that block
Tcf/Lef target gene expression in the absence of activated
b-catenin [15].
Materials and Methods
ES cell culture and differentiation
Undifferentiated mouse ESCs were maintained in 0.1%
gelatin-coated tissue culture flasks in a complete medium
composed of DMEM (Invitrogen), 10% fetal bovine serum
(Atlanta Biologicals), 50mM HEPES (Sigma), and 1mM
b-mercaptoethanol (Sigma) with 5 ng/mL LIF (Chemicon).
Neural-permissive culture conditions were achieved by
plating cells at low density (*2.0 · 104 cells per cm2) in
gelatin-coated 6- or 12-well plates in 20% Neural basal
medium (Invitrogen), 80% Ham’s F12 medium (Invitrogen)
with N2 and B27 salts (Invitrogen), 1mM retinoic acid (Sig-
ma), and 0.05% knockout serum replacement (Invitrogen).
To form EBs, cells were plated at 1.25 · 105 cells per mL in
nonadherent Petri dishes in medium consisting of DMEM
(Invitrogen), 10% fetal bovine serum (Atlanta Biologicals),
50mM HEPES (Sigma), and 1mM b-mercaptoethanol (Sig-
ma) for 4 days, and then transferred to gelatin-coated 12-well
dishes for an additional 2 days of adherent culture in the
same medium. Cells were maintained at 37C with 5% CO2.
To test their differentiation potential in the intact animal,
control and induced transgenic ESC were injected over the
flank of NOD SCID-gamma (NSG) mice (The Jackson La-
boratory). Geminin expression was induced for 4 days before
implantation, and control cells were maintained in culture
for a similar period. Cells were trypsinized, pelleted, and
1 · 106 cells in a volume of 250 mL injected subcutaneously.
After 3–6 weeks, when obvious tumors were present, ani-
mals were sacrificed, tumors photographed, and embedded
without fixation in OCT. Frozen sections were cut and stained
with hematoxylin and eosin or immunohistochemical local-
ization of cell-type-specific antibodies (described in the follow-
ing section) carried out to confirm the presence of multiple
lineages in the teratoma.
Plasmid construction and transfection
Geminin shRNA plasmids were described previously [16].
The H1 promoter was used to drive expression of the
shRNA, while a separate eGFP cassette driven by the CMV
promoter was used to identify transfected cells and monitor
the transfection efficiency (Fig. 7A). ESC were passaged 12 to
24 h before transfection and plated in gelatin-coated 6-well
plates (2.5 · 104 cells per cm2) in complete medium with LIF.
ES cells were transfected with Lipofectamine Plus (Invitrogen)
as directed by the manufacturer and cultured overnight in se-
rum-free conditions (OptiMem; Invitrogen), followed by EB
medium before RNA extraction, western blotting, or immuno-
histochemistry (IHC), as described below.
Inducible expression of Geminin in ESC
We obtained the MGZRTcH2 ESC cell line and the corre-
sponding exchange vector from Dr. Shinji Masui [17]. This cell
line contains a tetracycline-regulated transactivator, a tetra-
cycline-response element, followed by the minimal promoter
of the human cytomegalovirus (hCMV*-1) immediate early
gene, a hygromycin resistance cassette, directional loxP sites,
and an IRES-Venus (yellow fluorescent protein) cassette
knocked-in to the endogenous ROSA26 promoter. The corre-
sponding exchange vector replaces the hygromycin resistance
cassette with the desired cDNA in addition to adding a pu-
romycin resistance cassette. When the exchange vector is
correctly enzymatically recombined into the ROSA26 locus,
the resulting clones are no longer hygromycin resistant, but
are puromycin resistant—allowing both positive and negative
selection, thereby ensuring the elimination of cells with ran-
dom integration of the exchange vector (Fig. 1A).
A polymerase chain reaction (PCR)-cloned and sequence-
verified Geminin cDNA was inserted into one exchange
vector. A control exchange vector with no cDNA was also
generated to develop control cell lines that are puromycin
resistant and express the Venus protein upon doxycycline
(Dox) withdrawal. Each exchange vector was transfected
into the MGZRTcH2 cell line with a Cre recombinase vector,
followed by selection with 2mg/mL puromycin (Sigma).
Clones were expanded in complete medium with 1mg/mL
Dox (Sigma) to inhibit transgene expression and 2mg/mL
puromycin to maintain selection, and several selected to de-
termine their differentiation capability. Clones were checked
for random integration with 100mg/mL hygromycin (Sigma).
Overexpression of Geminin was verified by western blot and
quantitative PCR. During all differentiation experiments, se-
lection was maintained with 4mg/mL puromycin, and Ge-
minin expression was induced by Dox withdrawal (tet-off).
Cell cycle analysis
Cells were grown in EB medium for 6 days. On day 4, cells
were plated at 2 · 105 cells/well in 6-well plates in triplicate
in EB medium. After 48 and 96 h, cells were trypsinized and
counted using a Coulter Counter (BD). For cell cycle analysis,
samples were fixed by adding cold absolute ethanol and kept
at - 20C until analysis. Fixed cells were resuspended in PBS,
and DNAse-free RNase A (Sigma) was added to a 20mg/mL
final concentration. Samples were incubated at 37C for
30min, and DNA was labeled with 0.1mg/mL propidium
iodide (Sigma). Cells were sorted in a FACSCalibur using
Cell Quest Pro MAC 9.0 and Mod Fit LT Mac 3.1 SP3 for cell
cycle analysis.
Immunohistochemistry
ES cultures were fixed with 2% paraformaldehyde (PFA)
for 15min at room temperature and washed twice with PBS.
Fixed cells were blocked in 10% donkey serum for 30min, fol-
lowed by an overnight incubation at 4Cwith primary antibody
(rabbit anti-Sox3: Mike Klymkowski, University of Colorado,
1:1,000; goat anti-Oct3/4: Santa Cruz, 1:500; rabbit anti-
Foxa2:UpstateBiotechnology, 1:500;mouseanti-E-cadherin:Cell
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Signaling, 1:500; goat anti-Brachyury: Santa Cruz, 1:500; anti-
activated b-catenin: Millipore; 1:250; or rabbit anti-phospho-
histone H2A.X antibody: Cell Signaling, 1:500). Cells were then
washed with PBS and incubated with secondary antibodies
(1:400) conjugated to Cy3 or FITC (Jackson Immunoresearch)
for 2h at room temperature. Nuclei were visualized with
Hoechst 33258 (Sigma), and images were obtained using an
Leica DM inverted fluorescence microscope and an Olympus
DP70 camera with associated software.
Quantitative RT-PCR
RNA was harvested with Trizol (Invitrogen) following the
manufacturer’s protocol, and genomic DNA was removed
by DNAse digestion (Sigma). Complete DNA digestion was
confirmed by semiquantitative PCR using primers for b-actin
before reverse transcription. About 0.5 to 1.0mg RNA sam-
ple was used for reverse transcription with Verso RT
(Thermo Scientific) using random nonamers (Invitrogen)
following the manufacturer’s protocols. For quantitative
PCR, cDNAs were diluted 1:2, and 1mL was used per reac-
tion with the ABgene SYBR green master mix. All primer
pairs were rigorously screened to eliminate the primer di-
mer, and reaction conditions were optimized, producing
reaction efficiencies between 90% and 110%. Quantitative
PCR results were calculated, and statistical analysis per-
formed with REST2008 software [18]. Primer sequences and
detailed reaction conditions are available upon request.
Western blotting
ESC were lysed in an RIPA buffer (50mM Tris–HCL,
pH7.4, 1% NP-40, 0.25% Na-deoxycholate, and 150mM
NaCl2) with Complete protease inhibitor (Roche), cell debris
FIG. 1. Geminin can be inducibly expressed in embryonic stem cells (ESC). (A) Expression of Geminin from the ROSA26 locus
can be controlled by doxycycline (Dox). (a) In the presence of the tetracycline analog Dox, the tetracycline-regulated transac-
tivator (tTA) is unable to bind to the hCMV*-1 promoter (tetracycline-response element, followed by the minimal promoter of
the human cytomegalovirus immediate early gene) to initiate downstream gene expression. (b) Once Dox is removed from the
tissue culture medium, the tTA binds the hCMV*-1 promoter, and Geminin and Venus proteins are transcribed. (c) Control cells
inducibly express Venus, but lack the Geminin cDNA. (B) Geminin can be inducibly expressed in ESC. Western blot of protein
from control (C) and Geminin (Gem) ESC lines grown for 2, 4, and 6 days without Dox to induce transgene expression. Full-
length Geminin is the middle band (arrow) at 33 kDa. At 2 days of induction Geminin expression was increased in Geminin ESC,
and by 4 days and continuing through 6 days, Geminin was strongly overexpressed compared to control cells. Color images
available online at www.liebertpub.com/scd
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was pelleted by centrifugation, and the protein-containing
supernatant was removed and analyzed using the Pierce
Protein Assay to determine total protein concentration.
Ten to 30mg of protein was loaded onto 10% or 12% poly-
acrylamide SDS PAGE gels and then transferred to PVDF
membranes. Membranes were blocked with 5% milk pow-
der/TBST (Tris-buffered saline and 0.2% Tween 20) and in-
cubated with rabbit anti-Geminin (1:2,000; Santa Cruz), anti-
activated b-catenin (1:2,000; Millipore), goat anti-Tcf3 (1:500;
Santa Cruz), goat anti-panTLE (1:500; Santa Cruz), mouse
anti-E-Cadherin (1:20,000; Cell Signaling), mouse anti-N-
Cadherin (1:5,000; Life Technologies), and/or mouse anti-b-
actin (1:10,000; Sigma) primary antibodies in 5% milk pow-
der/TBST overnight at 4C. Membranes were washed in
TBST and incubated for 1 h at room temperature in a horse-
radish peroxidase-conjugated secondary antibody (1:1,000–
1:10,000; Jackson Immunoresearch). Membranes were devel-
oped using a Pierce Supersignal West Pico chemiluminescent
substrate. Western blotting was done on 3 Geminin transgenic
cell lines and was repeated at least 3 times each.
Cell migration assay
To determine if cells overexpressing Geminin would more
rapidly recolonize a wound, 3 lines of Geminin transgenic
ESC were plated in triplicate at 5 · 105 cells per well in gelatin
coated 6-well plates in EB medium –Dox. After 5 days of
transgene induction, a cell scraper was used to remove a
strip of cells from the middle of each dish, and the medium
changed immediately. On 5 sequential days of culture, 5
photomicrographs (at different levels of the scrape) were
taken from each of 3 replicate cultures –Dox, with 3 biolog-
ical replicates (n = 45 photomicrographs per timepoint) for
each of the 3 lines. The distance between the cut edges was
measured on each day and averaged, and significant differ-
ences were determined by matched-pair t-test.
TOP-/FOPFlash assay
Control and Geminin ESC were grown in adherent cul-
ture in EB medium for 48 h to induce transgene expression,
in the presence and absence of the GSK3b inhibitor Chir-
on99021 (10 mM) as a positive control. Cells were transfected
with TOPFlash or FOPFlash plasmids (Millipore) using Li-
pofectamine Plus (Invitrogen) according to the manufactur-
er’s instructions. A Renilla plasmid (pRL-CMV; Promega)
was cotransfected as an internal vector control. After 24 h,
cells were lysed with passive lysis buffer and subjected to the
Dual-luciferase assay (Promega) according to the manufac-
turer’s directions. Samples were read with a Veritas micro-
plate luminometer (Turner Biosystems). Data are expressed
as the ratio of TOPFlash relative to Renilla over FOPFlash
relative to Renilla, and significance was assessed using the
Wilcoxon signed-rank test.
Nuclear b-catenin assay
To further interrogate the status of Wnt-signaling path-
way members in Geminin-overexpressing ES cells, we de-
termined the percentage of cells in which b-catenin was
present in the nuclei. Control and 2 Geminin transgenic cell
lines (G12 and G17) were grown without Dox to induce
transgene expression, with Dox (negative control), or cells
gown with Dox and the GSK3-b inhibitor Chiron99021
(10 mM) to stimulate the Wnt pathway (positive control).
After 72h, cells were fixed in 2% PFA and stained with anti-
b-catenin antibodies and with the Hoechst dye to label nu-
clear DNA. Quantification was carried out by counting the
number of b-catenin + nuclei divided by the total number of
(Hoechst + ) nuclei in 10 fields from 4 replicate cultures with
3 biological replicates (120 fields per group). Data are ex-
pressed as means of the 3 biological replicates – SD, and
statistically significant differences between the treatment
groups were determined using the Wilcoxon signed-rank
test, followed by matched-pair tests.
Coimmunoprecipitation
Control and Geminin ESC were grown in EB medium for
4 days to induce transgene expression. Cells were scraped
from the tissue culture dishes and lysed in Blenis lysis buffer
(10mM KPO4, 1mM EDTA, pH7.0, 5mM EGTA, pH7.2,
10mM MgCl2, 50mM b-glycerol phosphate, and 0.3%
Chaps) with Complete protease inhibitor (Roche). Protein
samples were divided in half, and 2mL of goat anti-TLE
(Santa Cruz) or rabbit anti-Geminin (Santa Cruz) antibodies
were added to an aliquot of each sample set and incubated
overnight at 4C with end-over-end agitation. Preblocked
Protein A or Protein G Sepharose beads (GE) were added to
samples with antibody as well as to samples with input
protein alone as a negative control and incubated for 1 h at
4C with end-over-end agitation. Samples were centrifuged,
and the supernatant was saved for a loading control. Se-
pharose beads were washed 3 times with a lysis buffer at
4C. The loading buffer was added to the Sepharose beads,
and the samples were boiled for 5min to release the anti-
body/antigen complexes from the beads before analysis by
western blot as described above.
Results
Geminin can be inducibly expressed in ESC
To explore the effects of increasing levels of Geminin
protein in ESC, we created cell lines that express Geminin
when Dox is removed from the culture medium (Tet-off;
Fig. 1A). Twenty-four Geminin and 24 control (puromycin-
resistant cells that inducibly express only Venus yellow fluo-
rescent protein) ESC lines were cloned and expanded for
further study. Accurate targeting was verified by testing for
both hygromycin sensitivity and puromycin resistance, as well
as verification that Geminin was overexpressed only in the
absence of Dox. Several lines were selected for additional
study based on Dox-regulated Geminin protein over-
expression and/or Venus protein expression. Geminin protein
levels were increased 2 days after Dox withdrawal, and by
4 days, Geminin expression was significantly elevated com-
pared to control ESC and remained overexpressed at 6 days
(Fig. 1B). These data indicate that the Geminin protein can be
reliably overexpressed in response to Dox withdrawal.
Geminin promotes neural precursor and neuronal
differentiation in monolayer culture
To examine their neural differentiation potential, cells
were grown in defined, neural-permissive medium at low
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density for 6 days of transgene induction. In all 3 lines tested,
compared with the same uninduced cell lines, Geminin
overexpression promoted differentiation of both Sox3 +
neural precursors and Tuj1-positive primitive neurons
(Supplementary Fig. S1; Supplementary Data are available
online at www.liebertpub.com/scd). ImageJ analysis of cell
numbers indicated that there are modest increases in the
number of Sox3-positive neural precursors compared with
uninduced control cells (P £ 0.12) and a small, but not
significant (P £ 0.08), increase in Tuj1-positive neurons in
Geminin-expressing, compared with uninduced, cells.
Geminin promotes EMT and mesendodermal
differentiation in EBs
To examine the role of the Geminin protein in ESC dif-
ferentiation, we also employed a three-dimensional (3D)
differentiation assay. Cells were plated in nonadherent Petri
dishes in the absence of LIF and Dox, but with 10% serum,
promoting the formation of EBs and inducing differentiation.
Because some tetracycline derivatives, including Dox, inhibit
matrix metalloproteinases [19], potentially reducing EMT in
control cells grown in the presence of Dox, we compared 3
Geminin-inducible lines and a control line that lacked the
inserted Geminin cDNA both cultured without Dox.
Most Geminin-overexpressing EBs attached to the non-
adherent Petri dish 3 to 4 days after Dox withdrawal, and the
cells rapidly migrated from the EB (Fig. 2). However, the vast
majority of control EBs remained intact and floating for the
entire 6-day assay. Therefore, to force the attachment of
control EBs and promote differentiation, cells were grown as
floating EBs for 4 days and then replated onto adherent tis-
sue culture dishes for an additional 2 days before fixation for
IHC or harvesting of RNA. Geminin EBs expressed strikingly
less E-cadherin protein compared with control EBs (Fig. 2A)
and downregulated E-cadherin at the level of transcription in
quantitative PCR (Fig. 3B). We also examined E-cadherin and
N-cadherin expression by western blot in 3 cell lines cultured
as EBs with and without Dox for 2, 4, and 6 days (Fig. 5A),
which identified a reduction in E-cadherin protein levels
FIG. 2. In three-dimensional culture, Geminin promotes epithelial-to-mesenchymal transition (EMT) and mesendodermal
differentiation. (A) Immunohistochemical localization of E-Cadherin in a control (C) cell line and in Geminin (Gem) ESC
grown without Dox as embryoid bodies (EBs) for 4 days, followed by 2 days in adherent culture. Compared to controls that
express high levels of E-Cadherin (a), Geminin overexpression dramatically downregulated the expression of E-Cadherin
protein (b), a hallmark of cells that have undergone EMT. Control EB have attached, but cells have not yet migrated from
them as illustrated by Hoechst staining (c), unlike Geminin-overexpressing EBs that attach, and cells migrate rapidly from the
EB (d). (e) and (f) are overlays of ac and bd. Scale bar= 200mM. (B) Localization of cell-type-restricted proteins in control (C)
and Geminin (Gem) ESC grown as in (A) above. Geminin overexpression decreased the expression of the pluripotency
marker (Oct3/4; a, b) and of a neural precursor marker (Sox3; c, d), but increased expression of a mesodermal marker
(Brachyury; e, f) and a marker of the endoderm lineage (Foxa2; g, h). The nuclei were stained with Hoechst 33258 (blue). Scale
bar = 200mM. Color images available online at www.liebertpub.com/scd
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after 4 and 6 days of transgene induction and a concomitant
upregulation of N-cadherin protein and mRNA 6 days after
transgene induction.
When the expression of lineage-restricted markers was
examined by IHC (Fig. 2B), compared with controls, Gemi-
nin overexpression decreased the expression of the pluripo-
tent stem cell marker Oct3/4 and of the neural precursor
gene Sox3, while the mesodermal marker Brachyury and the
endoderm-restricted protein Foxa2 increased (Fig. 2B). We
also examined the expression of lineage-restricted markers
(Fig. 3A) and genes involved in EMT (Fig. 3B) in quantitative
PCR. Geminin overexpression decreased Oct3/4 and the epi-
blast marker FGF5, indicating that the Geminin-over-
expressing cells differentiated more rapidly than control ESC.
Markers of the mesendodermal lineage, BMP4, Brachyury,
and Sox17, were significantly increased, whereas the epider-
mal ectoderm marker Claudin6, Sox3, and the neuronal dif-
ferentiation marker Tuj1 were decreased. Expression of genes
involved in EMT, Snail1, Snail2, Twist1, and Twist2, was also
increased in Geminin-overexpressing cells, and E-cadherin
downregulated. Taken together, these data indicate that Ge-
minin controls the expression of genes involved in EMT.
A wounding assay was used (Fig. 4) to characterize the
highly migratory phenotype resulting from Geminin over-
expression. Geminin-overexpressing cells (n=3 transgenic
lines–Dox) migrated rapidly from the edge of a scraped mono-
layer; after 4 days, the denuded region had been completely re-
colonized by Geminin-overexpressing ESC, while in uninduced
control cultures after 5 days, a mean gap of 178.3–7.1mm re-
mained (Fig. 5). This is consistent with our observations that Ge-
minin promotes rapid EMT both in EBs and in the early embryo
[20], andwith the induction of genes involved in cell migration in
Geminin-overexpressing ESC (Fig. 3B).
Geminin does not affect trilineage differentiation
in teratomas
Geminin overexpression increased the rate at which tera-
tomas formed in NSG mice, but all the 3 germ lineages were
present in the tumors. Of the 6 subcutaneous injections, all
formed teratomas > 1 cm in diameter after 3 weeks, while
injection of uninduced ESC in 4 flanks produced similar-
sized tumors after 4–6 weeks in vivo. Histological analysis of
the teratomas indicated that the Geminin-overexpressing
teratomas contained derivatives of all 3 germ layers, but also
contained undifferentiated Oct3/4-positive cells, and did not
exhibit the complex tissue differentiation characteristic of
control teratomas, possibly because of the short interval be-
fore the animals were sacrificed (data not shown). Teratomas
developed from control ESC contained a complex mixture of
endoderm, mesoderm (muscle and cartilage), and neuronal
cells (data not shown). The tet-off system is particularly
useful in transplantation paradigms, as it insures continued
expression of the transgene in vivo, unlike constructs that
require the continued presence of an inducing agent.
Geminin overexpression stimulates Wnt
signaling in ESC
Because Wnt signaling plays a critical role in formation
of the primitive streak and mesendodermal differentiation
in the early mouse embryo, we examined the status of
Wnt pathway signaling in Geminin-overexpressing ESC.
Induction of Geminin protein expression significantly in-
creased canonical Wnt signaling in the TopFlash luciferase
assay compared to controls (Fig. 5B, Control vs. Geminin,
**P £ 0.01), which was approximately equal to the increase in
Wnt signaling produced by exposure of control cells to the
Gsk3b inhibitor Chir99021 (Control + chiron vs. Geminin,
P £ 0.70, and Control vs. Control+ chiron *P£ 0.02), previ-
ously shown to promote Wnt signaling [21]. In addition, a
well-characterized canonical Wnt target gene, Axin2 [22–25],
FIG. 3. Analysis of gene expression in Geminin versus
control EBs. Quantitative PCR of mRNAs from EBs grown for
6 days as described in Fig. 2A. Box-and-whisker plots were
produced with REST software [18]. The top and bottom
whiskers indicate the range, while the box indicates the upper-
and lower-quartile values. Gene expression was calculated
relative to b-actin and set to 1 in the control ESC line. Asterisks
indicate statistically significant differences (Geminin vs. con-
trol, P £ 0.05) calculated by the REST software (n = 3 repli-
cates). (A) Geminin overexpression decreased expression of
the pluripotency gene Oct3/4 ( - 2.5-fold) and of the epiblast
gene FGF5 ( - 2.0-fold). There was increased expression of the
mesendodermal markers BMP4 (35.2-fold) and Sox17 (12.8-
fold), and there was a trend toward increasing Brachyury
expression (10.3-fold) in Geminin EBs. Finally, there was re-
duced expression of the epidermal ectoderm marker Claudin6
( - 2.5-fold) and of the neural precursor marker Sox3 ( - 2.5),
and of Tuj1 (- 2.3-fold). (B) Geminin overexpression (21.9-
fold) increased the expression of the Wnt pathway target
Axin2 (7.7-fold). There was a trend toward increased Snail1
expression (3.1-fold), as well as significant alterations in sev-
eral other genes involved in EMT after Geminin over-
expression, including Snail2 (8.8-fold), Twist1 (4.8-fold), and
Twist2 (73.4-fold). E-cadherin expression was decreased 3.3-
fold in Geminin cells compared to control cells. Color images
available online at www.liebertpub.com/scd
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was upregulated over 7-fold after Dox withdrawal in an
EB culture (Fig. 3B). Geminin ES cells failed to activate the
TopFlash reporter, andAxin2 gene expressionwas unchanged
in the presence of Dox (data not shown). These data indicate
that in ESC, Geminin overexpression functions to stimulate
Wnt signaling as was observed in Wnt indicator mice [20].
Since BMP signaling is also required for mesendodermal dif-
ferentiation in the mouse embryo, we examined BMP4 and
Axin2 expression after 3 days of EB differentiation by quan-
titative PCR. Axin2 was increased 57-fold, while BMP4 was
only increased 3-fold, suggesting that Geminin promotesWnt
signaling that may in turn upregulate BMP4 expression.
To examine the mechanisms underlying Geminin’s ability
to stimulate Wnt signaling, we examined the percentage of
cells in which b-catenin was present in the nucleus, indicating
pathway activation. In the presence of Dox, 26.4% – 0.7% of
Control, 27.7% – 1.4% of Geminin line12, and 26.1% – 0.7%
Geminin line17 cells exhibited nuclear b-catenin. The path-
way agonist chiron strongly stimulated nuclear localization of
b-catenin: 89.0% – 3.0% of Control, 90.7% – 4.0% of G12, and
88– 0.6% of the G17 cells exhibited nuclear b-catenin. When
grown in the absence of Dox to activate transgene expression,
there were baseline levels of nuclear b-catenin in both Control
cells (27.1% – 0.9%) and in Geminin-overexpressing cells
(28.3% – 1.1%; Line G12, and 26.7% – 1.9%; Line G17)
(Fig. 5D). Differences between themeanswere not statistically
significant. These data suggest that Geminin stimulates
Wnt signaling via a mechanism that is unlikely to involve
b-catenin.
Geminin may induce Wnt signaling by binding
TLE proteins
To begin to identify the mechanisms by which Geminin
promotes Wnt signaling, we first examined the expression of
the Wnt pathway members. Geminin did not dramatically
FIG. 4. Geminin promotes
rapid recolonization of a
scrape wound. (A) Low- (a,
b) and high- (c, d) magnifi-
cation phase-contrast micro-
graphs of Control (a, c) and
Geminin-overexpressing (b,
d) ES cells, demonstrating
that Geminin overexpression
produces highly migratory
cells that rapidly colonize a
wound in the cell monolayer
after 4 days. Arrows= edge of
scraped cells. Scale bars= 200
mM. (B) Three lines of Gemi-
nin ESC (lines 12, 14, and 17)
grown –Dox were tested for
their ability to close a scrape
wound. When Geminin was
overexpressed, cells (n = 3
lines, G1, G2, and G3) com-
pletely closed a 350-mM
wound in the cell monolayer
a full 2 days earlier than un-
induced ESC (dashed lines, C1,
C2, and C3). On day 1, the
mean gap Control versus
Geminin was 362– 13.1 mi-
crometers versus 361– 20.8;
on day 2: 282.3– 4.2 versus
199.3– 29.4, P £ 0.01; on day
3: 250.7– 6.6 versus 37 – 12,
P £ 1.4 · 10 - 6; by day 4 of
culture controls: 220.7– 6.8;
and on day 5: 178.3 – 7.1 mM.
Color images available online
at www.liebertpub.com/scd
GEMININ PROMOTES EMT IN EMBRYONIC STEM CELLS 1183
increase the level of activated b-catenin protein (Fig. 5C) or
affect its localization (Fig. 5D), suggesting that Geminin does
not regulate expression of Wnt ligands or inhibit GSK3b.
Expression of TLE proteins, which are required for Wnt
pathway inhibition, was largely unchanged by Geminin
overexpression (Fig. 5E). There was a small, but consistent,
increase in expression of Tcf3 (Fig. 5F), which typically inhibits
theWntpathway, in response to increasedGeminin.While this
may seem inconsistent with the observed increase in the Wnt
pathway activity, it is likely a negative feedback mechanism.
Since Geminin has been reported to bind proteins in
the nucleus and inhibit their function, we performed
coimmunoprecipitation experiments with Tcf3 and Ge-
minin antibodies, but were unable to detect an interaction
(data not shown). However, there was a weak, but con-
sistent, interaction of Geminin with TLE proteins. Based
on this interaction, we hypothesize that Geminin may
bind and inhibit TLE proteins from repressing Wnt sig-
naling in the nucleus, thereby activating Wnt target gene
expression.
FIG. 5. Geminin overexpression stimulates Wnt signaling. (A) Geminin overexpression promotes expression of N-cadherin
and decreases expression of E-cadherin. (B) Geminin strikingly upregulated Wnt signaling, to nearly the same level as in
control cells treated with the GSK3b inhibitor Chir99021 (chiron—a Wnt pathway agonist), as assessed in luciferase assays.
The mean change (Relative Light Units TOP Flash/FOP Flash) in the Geminin line was significantly higher than the control
line grown without Dox (**P £ 0.01) as well as in control cells + chiron compared with control cells (*P £ 0.02) Student’s t-test
(n = 5). Error bars represent standard error of the mean. (D–F) Geminin does not influence expression of Wnt pathway
members, but binds nuclear Transducin-Like Enhancer of split (TLE) proteins. Control (C) and Geminin (Gem) mESC were
grown 2 (- 2 Dox), 4 ( - 4 Dox), and 6 ( - 6 Dox) days without Dox to induce transgene expression, and then protein was
harvested and used in western blotting. There was a little change in the expression or localization of activated b-catenin (C,
D) of TLE proteins that function to inhibit Tcf/Lef function (E) or of Tcf3, an inhibitory Tcf/Lef factor (F), with Geminin
overexpression. However, there was a consistent interaction of Geminin with TLE proteins in samples grown 4 days without
Dox as assayed by coimmunoprecipitation using an anti-Geminin antibody to pull-down and anti-TLE to blot (G). (D)
Control (C), and 2 Geminin transgenic cell lines (G12 and G17) were grown + Dox (negative controls), were grown in the
absence of Dox (-Dox) to induce Geminin transgene expression, or were treated with the GSK3b inhibitor chiron ( +Chir) to
stimulate the Wnt pathway. Cells that expressed nuclear b-catenin and Hoechest 33258 were counted, and data expressed as a
percentage of the b-catenin +/Hoechst + cells (% nuclear b-cat+ ).
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Geminin reduces proliferation and alters cell
cycle of ESC
Since Geminin inhibits DNA replication to prevent en-
doreduplication, we assayed proliferation and cell cycle
characteristics of Geminin and control ESC in monolayer
culture. In the presence of Dox, Geminin cell lines grow
similarly to the control cell line (data not shown). However,
overexpression of Geminin significantly reduced prolifera-
tion (Fig. 6A), increased the length of time the cells spent in
the G2/M phase of the cell cycle, and reduced the time spent
in the G1 phase (Fig. 6B). Decreased proliferation may itself
promote differentiation, since exit from the cell cycle is re-
quired for many cell fate decisions. Additionally, cells may
be unable to progress from G2/M, because they are unable to
initiate new rounds of DNA replication, since Geminin is
normally destroyed by the proteasome during the M phase.
Clearly, Geminin plays an important role in controlling cell
cycle and proliferation in ESC similar to its role in the inner
cell mass.
Geminin shRNA results in DNA damage
and cell death
To determine if Geminin protein is necessary for Wnt
signaling, lineage differentiation, and/or EMT, we employed
shRNAs (Fig. 7A) to reduce Geminin protein levels. We were
able to achieve a 6-fold knockdown of Geminin protein 24 h
post-transfection (Fig. 7B); however, cells transfected with the
Geminin shRNA exhibited increased DNA damage as illus-
trated by phosphohistone H2A.X antibody staining (Fig. 7C),
precluding the analysis of differentiation and Wnt signaling.
Cells transfected with the control shRNA showed some DNA
damage (11.4% – 0.6%) that increased dramatically when
Geminin was knocked down (84.3% – 0.1%), P £ 0.001.
Discussion
Geminin has previously been characterized by its ability to
promote neural differentiation at the expense of alternative
lineages in Xenopus [8,14] and Drosophila embryos [26]. Our
results demonstrate that the outcome of Geminin over-
expression in ESC is highly context dependent: in a sparse
monolayer culture, in defined medium, it can promote neu-
ral differentiation, while in 3D culture, as EBs with serum, it
promotes EMT and mesendodermal differentiation.
Given its context-dependent effects, it is not surprising
that 2 recent reports of Geminin gain and loss of function in
ESC come to remarkably different conclusions. The first
proposed that Geminin escapes degradation in ESC and in-
hibits the action of Brg1 to sustain Oct4, Sox2, and Nanog
expression, thereby maintaining pluripotency [27]. The sec-
ond study reported that Geminin controls neuronal differ-
entiation via regulation of chromatin, although without
corresponding alterations in protein expression or in pro-
moting differentiation [28]. Low levels of overexpression and
downregulation obtained in that study may have created a
state of chromatin readiness to respond to lineage differen-
tiation factors, rather than neuronal differentiation per se.
Recently, targeted deletion of Geminin in neural stem cells
suggested that in vivo Geminin may have a primary role in
cycle regulation rather than in lineage choice [29], although
another analysis demonstrated that deletion expanded the
neural precursor population, and overexpression promoted
migration and premature neuronal differentiation [30].
Our overexpression studies consistently demonstrate that
Geminin promotes, rather than inhibits, differentiation in
EBs; however, it remains possible that the outcome is de-
pendent on the level of expression or on the differentiation
state of the cell—producing different outcomes in ESC versus
lineage-committed neural precursors. Additionally, we were
unable to assess ESC differentiation in the absence of Ge-
minin protein, as we observed DNA damage in shRNA
transfected cells, likely not observed using siRNAs, since
Geminin is degraded and resynthesized during each cycle.
Geminin has been shown to bind and inhibit the function
of several nuclear factors, including AP4 [31], the chromatin-
remodeling protein Brg-1 [32], Hox proteins [33], and Six3
[34]. Geminin also has the potential to act as a molecular
switch between proliferation and differentiation by binding
additional transcription factors [35], including TLE proteins.
Tcf/Lef transcription factors inhibit Wnt signaling in the
absence of nuclear b-catenin [36,37], and our results suggest
that Geminin may inhibit interactions between Tcf/Lefs and
TLEs to de-repress Wnt signaling.
Wnt signaling is critically involved in establishing the
primitive streak and promoting the EMT required for me-
sendodermal differentiation in the embryo [38–44]. The
transcriptional repressors Snail1 and Snail2 both down-
regulate the expression of E-cadherin, and in the absence of
Snail1, mesendoderm is still specified; however, gastrulation
FIG. 6. Geminin overexpression decreases proliferation
and increases the length of the G2/M phase. (A) Control and
Geminin ESC were grown for 2 days in the absence of LIF
and Dox and then plated to assay proliferation. Geminin
overexpression reduced proliferation at 4 (*P £ 0.005) and 6
days (**P £ 0.0001) after Dox withdrawal; Student’s t-test,
n = 3. (B) Cell cycle analysis after 6 days of Dox withdrawal.
Geminin overexpression increased the length of G2/M
(*P £ 0.05) and decreased the length of G1 (**P £ 0.03 Student’s
t-test, n= 3). Color images available online at www
.liebertpub.com/scd
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fails because cells are unable to leave the primitive streak
[44,45]. It has been hypothesized that downregulation of
E-cadherin releases b-catenin from cytoskeletal junctional
complexes, increasing Wnt signaling [46,47] that in turn
feeds back to increase Snail1 [48–52]. However, it appears
that in our EB model, Geminin de-represses Wnt signaling to
promote Snail1 and Snail2 expression, suggesting that
Geminin should now be included in the list of genes that
initiate EMT and mesendodermal differentiation.
Wnt signaling is required for the proliferation of neural
precursors [53–56], for neuronal differentiation [57,58], and
patterning of the developing nervous system [59,60]. The key
bHLH transcription factors that drive neuronal specification,
including Neurog1 and NeuroD1, are transcriptional targets
of the canonical Wnt pathway [54,57,61]. Therefore, while
Wnt signal inhibition may initially be required to promote
neural precursor differentiation by inhibiting mesendodermal
lineage differentiation, active signaling appears to be required
for precursor proliferation and neuronal differentiation [62].
Wnt signaling has previously been shown to be required
for the differentiation of ESC to mesendoderm [63–65] and is
also implicated in the switch from the pluripotent to the
differentiated state via Tcf3 binding to a protein complex
with Oct4, Sox2, and Nanog on gene promoters [66–68]. In
many cell types, cell fate decisions are tightly coupled to the
cell cycle exit [36,69,70], and the most crucial decision in the
cell cycle, that is, to proliferate, differentiate, quiesce, senesce,
or apoptose, occurs at the G1 checkpoint [71]. The attenuated
G1 phase in adult stem cells, ESC, and the epiblast may
prevent differentiation by insulating cells from growth factor
exposure [72–74]. Overexpression of Geminin decreased
proliferation and increased the length of G2/M in both ESC
(above) and in early postimplantation embryos [20]. Persis-
tent Geminin protein expression without cyclic degradation
is likely to maintain the sequestration of Cdt1 and block
progression from the M phase. In turn, lengthening G2/M
would increase the time Geminin is available to interact with
other proteins in the nucleus and promote differentiation.
Our results suggest that Geminin, via its ability to de-repress
Wnt signaling, may be a key regulatory factor controlling cell
cycle, EMT, and differentiation at gastrulation.
Geminin expression has been negatively correlated
with patient prognosis in several cancers [10,75,76], where
it may promote EMT and therefore metastasis. In fact,
when Geminin was overexpressed in the MCF-10 non-
tumorigenic mammary epithelial cell line, there was in-
creased proliferation and anchorage-independent growth
[77,78]. Knockdown of Geminin protein might therefore be
a powerful approach to both inhibit metastasis and initi-
ate endoreduplication and apoptotic cell death in dividing
tumor cells.
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